Alliancebernstein L.P. Bio Atla, Inc. Transaction History

Alliancebernstein L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.13 - $5.38 $30,033 - $75,858	-14,100 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$19.0 - $30.95 $32,300 - $52,615	1,700 Added 13.71%	14,100 $277,000
Q3 2021 Nov 10, 2021	SELL	$29.44 - $43.74 $55,936 - $83,106	-1,900 Reduced 13.29%	12,400 $365,000
Q2 2021 Jul 30, 2021	BUY	$38.07 - $56.17 $376,893 - $556,083	9,900 Added 225.0%	14,300 $606,000
Q1 2021 May 06, 2021	BUY	$32.41 - $70.91 $142,603 - $312,004	4,400 New	4,400 $224,000

17.3M

500

33.5K

Ticker BCAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,304,100
Market Cap $62.4M
Description
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.